Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis/thrombo-inflammation and vascular biology.
News Clinical trial led by Bimingham Professor shows digoxin is effective for treatment of atrial fibrillation A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when used to treat patients with permanent atrial fibrillation and symptoms of heart failure.
News Major award for a new national approach to improving clinical research in the NHS to benefit patient care
Posted 01 February 2021 Clinical trial led by Birmingham Professor shows digoxin is effective for treatment of atrial fibrillation A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when used to treat patients with permanent atrial fibrillation and symptoms of heart failure.
Posted 27 January 2021 Sir Henry Wellcome Fellowship awarded to Dr Christopher O'Shea Dr Christopher O'Shea, Research Associate at the Institute of Cardiovascular Sciences, has been awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust.
Posted 13 January 2021 Hunterian Professorship awarded to Birmingham Clinician Scientist Mr Nigel Drury, Clinician Scientist in Paediatric Cardiac Surgery at the Institute of Cardiovascular Sciences, has received the prestigious Hunterian Professsorship for 2021.
Posted 04 January 2021 Institute of Cardiovascular Sciences welcomes new Birmingham Fellow Dr James Guggenheim has been appointed as a Birmingham Fellow with the Institute of Cardiovascular Sciences, joining its long established world class research team.